title: NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.
abstract: We hypothesized that diabetes-induced oxidative stress may affect postischemic neovascularization. The response to unilateral femoral artery ligation was studied in wild-type or gp91(phox)-deficient control or type 1 diabetic mice or in animals treated with the anti-oxidant N-acetyl-l-cysteine (NAC) or with in vivo electrotransfer of a plasmid encoding dominant-negative Rac1 (50 microg) for 21 days. Postischemic neovascularization was reduced in diabetic mice in association with down-regulated vascular endothelial growth factor-A protein levels. In diabetic animals vascular endothelial growth factor levels and postischemic neovascularization were restored to nondiabetic levels by the scavenging of reactive oxygen species (ROS) by NAC administration or the inhibition of ROS generation by gp91(phox) deficiency or by administration of dominant-negative Rac1. Finally, diabetes reduced the ability of adherent bone marrow-derived mononuclear cells (BM-MNCs) to differentiate into endothelial progenitor cells. Treatment with NAC (3 mmol/L), apocynin (200 micromol/L), or the p38MAPK inhibitor LY333351 (10 micromol/L) up-regulated the number of endothelial progenitor cell colonies derived from diabetic BM-MNCs by 1.5-, 1.6-, and 1.5-fold, respectively (P < 0.05). In the ischemic hindlimb model, injection of diabetic BM-MNCs isolated from NAC-treated or gp91(phox)-deficient diabetic mice increased neovascularization by approximately 1.5-fold greater than untreated diabetic BM-MNCs (P < 0.05). Thus, inhibition of NADPH oxidase-derived ROS overproduction improves the angiogenic and vasculogenic processes and restores postischemic neovascularization in type 1 diabetic mice.
authors.affiliation: Cardiovascular Research Center, U689-INSERM, Hôpital Lariboisière, 41 Blvd de la Chapelle, 75475 Paris Cedex 10, France.
authors.forename: Téni G
authors.initials: TG
authors.lastname: Ebrahimian
authors.forename: Christophe
authors.initials: C
authors.lastname: Heymes
authors.forename: Dong
authors.initials: D
authors.lastname: You
authors.forename: Olivier
authors.initials: O
authors.lastname: Blanc-Brude
authors.forename: Barend
authors.initials: B
authors.lastname: Mees
authors.forename: Ludovic
authors.initials: L
authors.lastname: Waeckel
authors.forename: Micheline
authors.initials: M
authors.lastname: Duriez
authors.forename: José
authors.initials: J
authors.lastname: Vilar
authors.forename: Ralph P
authors.initials: RP
authors.lastname: Brandes
authors.forename: Bernard I
authors.initials: BI
authors.lastname: Levy
authors.forename: Ajay M
authors.initials: AM
authors.lastname: Shah
authors.forename: Jean-Sébastien
authors.initials: JS
authors.lastname: Silvestre
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001853:Bone Marrow; D002454:Cell Differentiation; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced*; D042783:Endothelial Cells / Q000166:cytology; D007511:Ischemia; D051379:Mice; D009000:Monocytes / Q000166:cytology; D018482:Muscle, Skeletal / Q000098:blood supply*; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009389:Neovascularization, Pathologic; D021122:Protein Subunits / Q000378:metabolism; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D021122:Protein Subunits; D017382:Reactive Oxygen Species; D042461:Vascular Endothelial Growth Factor A; D019255:NADPH Oxidases